University of Washington

Material Transfer Agreements (MTA)

Transfer of Human Biological Material

Transfer of Human Biological Material

Transfer human biological material samples collected at UW to a third party:

The UW owner/sender of the bio-specimens must have IRB approval from the UW IRB (or an IRB that the UW relies upon through a written agreement) for the proposed external sharing, if the UW owner/sender can identify the specimens, either directly or indirectly through a link between a code and identifiers. De-identified (no identifying information associated with the samples would no longer meet the definition of human subjects and would not fall under our IRB purview.

For IRB approval, please contact the appropriate individual at Human Subjects Division who is familiar with your particular IRB application. If you are still unsure, contact the Human Subjects Division.

Jeanette Ennis

Associate Director of Innovation Investment

Jeanette Ennis supports UW researchers pursuing grant money to commercialize their innovations, and helps CoMotion secure economic development grant opportunities. Ennis joined CoMotion in 2009 after more than 15 years of broad research experience as a scientist, entrepreneur, and manager. Her areas of expertise include pharmacology, biochemistry, molecular biology, tissue engineering, and medical devices. She has worked with a variety of start-up companies as project manager, grant writer, and intellectual property manager, and held senior research positions at Cornell University and the UW Department of Cardiothoracic Surgery. She earned a doctorate in medical and molecular pharmacology from the University of California, Los Angeles, where she trained with Louis Ignarro, Nobel Laureate in Physiology. She also holds a certificate in technical writing and editing from the UW Department of Human Centered Design & Engineering.